Ziprasidone in Children With Autism: A Pilot Study

Completed · Phase 2

Conditions studied: Autism

In brief

The purpose of this study is to see if the drug, ziprasidone, is effective in treating problems in adolescent associated with autism.

Key facts

Study ID

NCT00208559

Run by

Drexel University College of Medicine

People needed

15

Starts

2002-02-01

Expected to finish

2006-08-01

Last updated by the study team

2010-06-17

Who can join

Age: 12 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of autism (DSM-IV) made by a boarded child and adolescent psychiatrist.
• Males and females.
• Aged 12 to 18 years.
• Clinical judgment that medication treatment for autism is indicated.

You may not qualify if…

• Major medical problems including cardiac, liver, endocrine, or renal diseases.
• History of seizure disorder or gross neurological deficit.
• Baseline QTC greater than 425 msec.
• Concomitant treatment with psychotropic medication.
• History of prior exposure to ziprasidone.

Where it is running

• Drexel University College of Medicine at Friends Hospital — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.